Opus Genetics Inc.

NASDAQ: IRD · Real-Time Price · USD
1.20
0.02 (1.69%)
At close: Aug 15, 2025, 3:39 PM

Opus Genetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
10.99M 19.05M 39.85M 589K
Cost of Revenue
10K 6K 4K 4K
Gross Profit
10.98M 19.05M 39.85M 589K
Operating Income
-62.07M -10.56M 18.23M -22.7M
Interest Income
n/a n/a n/a n/a
Pretax Income
-57.53M -9.97M 18.2M -56.69M
Net Income
-57.53M -9.99M 17.89M -56.69M
Selling & General & Admin
18.21M 11.96M 7.27M 8.12M
Research & Development
26.85M 17.65M 14.36M 15.17M
Other Expenses
28M n/a n/a n/a
Operating Expenses
73.07M 29.61M 21.62M 23.29M
Interest Expense
n/a 1.33M 9K 2K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
73.07M 29.61M 21.62M 23.29M
Income Tax Expense
n/a 12K 315K n/a
Shares Outstanding (Basic)
26.72M 21.59M 19.93M 14.85M
Shares Outstanding (Diluted)
26.72M 21.59M 20.6M 14.85M
EPS (Basic)
-2.15 -0.46 0.90 -3.82
EPS (Diluted)
-2.15 -0.46 0.87 -3.82
EBITDA
-57.52M -9.97M 18.22M -56.69M
EBIT
-57.53M -9.97M 18.21M -56.69M
Depreciation & Amortization
10K 6K 4K 4K